156 related articles for article (PubMed ID: 12501977)
1. Acromegalic arthropathy.
Barkan AL
Pituitary; 2001 Sep; 4(4):263-4. PubMed ID: 12501977
[No Abstract] [Full Text] [Related]
2. Acromegalic arthropathy and sleep apnea.
Barkan A
J Endocrinol; 1997 Oct; 155 Suppl 1():S41-4; discussion S45. PubMed ID: 9389994
[No Abstract] [Full Text] [Related]
3. Reversibility of joint thickening in acromegalic patients: an ultrasonography study.
Colao A; Marzullo P; Vallone G; Marinò V; Annecchino M; Ferone D; De Brasi D; Scarpa R; Oriente P; Lombardi G
J Clin Endocrinol Metab; 1998 Jun; 83(6):2121-5. PubMed ID: 9626149
[TBL] [Abstract][Full Text] [Related]
4. Acromegalic arthropathy. Characteristics and response to therapy.
Layton MW; Fudman EJ; Barkan A; Braunstein EM; Fox IH
Arthritis Rheum; 1988 Aug; 31(8):1022-7. PubMed ID: 2900639
[TBL] [Abstract][Full Text] [Related]
5. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
6. Locking of metacarpophalangeal joints in a patient with acromegaly.
Tani Y; Tanaka N; Isoya E
Skeletal Radiol; 1999 Nov; 28(11):655-7. PubMed ID: 10591930
[TBL] [Abstract][Full Text] [Related]
7. Acromegalic arthropathy of the hip: a case report.
Melikoglu MA; Sezer I; Kocabas H; Akdag A; Balci N
Acta Reumatol Port; 2008; 33(3):357-9. PubMed ID: 18846016
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
9. Another case where bigger is not better.
Weber KT
Cardiovasc Res; 1997 Oct; 36(1):1-2. PubMed ID: 9415265
[No Abstract] [Full Text] [Related]
10. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
Riedel M; Günther T; von zur Mühlen A; Brabant G
Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between integrated 24-hour concentrations of growth hormone, insulin-like growth factor I and prolactin in acromegalic patients treated with octreotide and patients treated with octreotide LAR].
Esposito V; Esposito D; Lo Iudice G
Minerva Endocrinol; 2001 Dec; 26(4):289-92. PubMed ID: 11782718
[TBL] [Abstract][Full Text] [Related]
12. Rebound hypersecretion of GH following octreotide withdrawal due to liver dysfunction in an acromegalic patient.
Shimatsu A; Murabe H; Nakamura Y; Usui T
Endocr J; 2000 Oct; 47(5):635-8. PubMed ID: 11200946
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly and prostate cancer.
Colao A; Marzullo P; Spiezia S; Lombardi G
Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S37-8. PubMed ID: 10984287
[No Abstract] [Full Text] [Related]
14. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
[TBL] [Abstract][Full Text] [Related]
15. Octreotide treatment of acromegaly during pregnancy.
Mikhail N
Mayo Clin Proc; 2002 Mar; 77(3):297-8. PubMed ID: 11888040
[No Abstract] [Full Text] [Related]
16. The role of Sandostatin in acromegaly.
Sassolas G
Metabolism; 1992 Sep; 41(9 Suppl 2):39-43. PubMed ID: 1518432
[TBL] [Abstract][Full Text] [Related]
17. Endocrine applications of the somatostatin analogue octreotide (Sandostatin).
Ezzat S; Melmed S
Metabolism; 1992 Sep; 41(9 Suppl 2):34-8. PubMed ID: 1518431
[No Abstract] [Full Text] [Related]
18. Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion.
Lim MJ; Barkan AL; Buda AJ
Ann Intern Med; 1992 Nov; 117(9):719-26. PubMed ID: 1416573
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
van der Lely AJ; Harris AG; Lamberts SW
Clin Endocrinol (Oxf); 1992 Aug; 37(2):181-5. PubMed ID: 1395069
[TBL] [Abstract][Full Text] [Related]
20. [Experience in treating acromegalic patients with long-acting octreotide].
Szücs N; Mészáros J; Czirják S; Mondok A; Varga I; Gláz E
Orv Hetil; 2002 May; 143(19 Suppl):1066-70. PubMed ID: 12063862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
